Irish-led project to treat diabetes with a cheek patch bags €3.8m from EU
Led by UCD’s Prof David Brayden, Buccal-Pep aims to treat Type 2 diabetes by administering peptides such as insulin through the cheek.
Source: siliconrepublic.com
Stay updated with breaking news from Prof David Brayden. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Led by UCD’s Prof David Brayden, Buccal-Pep aims to treat Type 2 diabetes by administering peptides such as insulin through the cheek.
A project to develop a patch worn on the cheek that delivers peptide treatments for type 2 diabetes has been awarded just under €3.8 million.